Membio's bioreactor technology acquired by ABEC

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Membio’s bioreactor technology has been acquired by ABEC, a leading global supplier of stainless steel and single-use integrated solutions and services for biopharmaceutical manufacturing. When brought to market, this technology will give customers a significant advantage in manufacturing their cellular products.

Membio is an alumnus of our BDSP™ and WiHI programs.

Arsheen Kaur
Previous

Nanostics receives funding from the University of Alberta Innovation Fund to propel adoption of the ClarityDX Prostate test
Next

KA Imaging's inCiTe 3D X-ray Microscope to support orthopaedic research at the University of Waterloo